Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update evaluating dopaminergic therapy in patients with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-13Clinical Trial Update: Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 clinical trial of masitinib (AB1010) in mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study [Phase 3]
Phase 3 trial evaluating intepirdine (RVT-101) in mild-to-moderate Alzheimer's disease patients on donepezil completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating the efficacy and safety of PF 04494700 in mild to moderate Alzheimer's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo [Phase 2]
Phase 2 proof-of-concept study comparing BI 409306 to placebo in Alzheimer disease completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease [Phase 2]
Phase 2a dose-finding and PK/PD study of ANAVEX2-73 in Alzheimer's disease completed.
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: Imaging Tau in Alzheimer's Disease and Normal Aging [Phase 2]
Phase 2 clinical trial related to imaging tau in Alzheimer's disease and normal aging has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. [Phase 2]
Phase 2 clinical trial update for BI 409306 in cognitive impairment due to Alzheimer’s disease; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease [NA]
A completed clinical trial investigating the effect of walking on brain fuel consumption in individuals with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease [Phase 3]
Phase 3 clinical trial of GV-971 (sodium oligomannurarate) for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: Specialized Food Plan Based on Individual Physiological Comprehensive Body Assessments Accompanied With Cellular Repair Therapy to Decrease Inflammation Cognitively Impaired Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a specialized diet plan combined with cellular repair therapy to reduce inflammation in patients with mi…
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016) [Phase 1]
Phase 1 open-label study of MK-8931 in participants with hepatic impairment; results completed with conditions including amnestic mild cogni…
-
CLINICAL_TRIALS trial_result · 2018-09-24Clinical Trial Update: A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease [Phase 2]
Phase 2a study evaluating rilapladib (SB-659032) in Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: Webnovela for Hispanic Dementia Family Caregivers [NA]
A completed clinical trial update for Webnovela aimed at Hispanic dementia family caregivers; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: To Evaluate the Efficacy and Safety/Tolerability Profiles of G-CSF in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety/tolerability of G-CSF in subjects with mild to moderate Alzheimer's disease has …
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation [NA]
A completed clinical trial investigated non-invasive brain stimulation to enhance spatial navigation in individuals with mild cognitive impa…
-
CLINICAL_TRIALS trial_result · 2018-08-23Clinical Trial Update: Alzheimer's Disease: Therapeutic Potential of Estrogen [Phase 2, Phase 3]
Clinical trial update evaluating the therapeutic potential of estrogen for Alzheimer’s disease in Phase 2/Phase 3 has been completed.
-
CLINICAL_TRIALS trial_result · 2018-08-20Clinical Trial Update: The Depression in Alzheimer's Disease Study (DIADS) [Phase 4]
A Phase 4 clinical trial update for the Depression in Alzheimer's Disease Study (DIADS) has completed; the study investigates depression in …
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease [Phase 3]
Phase 3 clinical trial on long-term safety and tolerability of idalopirdine (Lu AE58054) as add-on to donepezil in mild-to-moderate Alzheime…
-
CLINICAL_TRIALS trial_result · 2018-08-09Clinical Trial Update: Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202) [Phase 2]
Phase 2 trial results for T-817MA in mild-to-moderate Alzheimer's disease have been completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg [Phase 3]
Phase 3 trial updating the optimal dose escalation strategy to achieve high-dose donepezil 23 mg for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]
Phase 1/2 feasibility study in adults with mild to moderate Alzheimer's disease completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]
Phase 1/2 clinical trial of CT1812 in mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease [Phase 3]
Phase 3 trial of solanezumab in prodromal Alzheimer's disease was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001) [Phase 1]
First-in-human validation study of the PET tracer [18F]MK-6240 (MK-6240-001) completed in Phase 1 for Alzheimer's disease and amnestic mild …